News
News
Announcements from Bandit Biosystems, followed by an archive of press releases and posts originally published by SeqOnce Biosciences, Inc. Technical notes now have their own section: technical notes.
Bandit Biosystems news
- Oct 2026
Company newsReadA New Home at bandit.bio
Our new website puts full specifications, target lists, tube and dye layouts and ordering details for every product in one place.
- Oct 2026
Product launchReadDesign Your Own Panel
A new online panel designer lets labs lay out a custom multiplex qPCR panel in minutes and send it to our team for a feasibility review.
- Apr 2026
Product launchReadWomen's Health Panel C Ready-2-Test
A 33-target multiplex qPCR kit for sexually transmitted pathogens, vaginal flora, Candida species and 18 antibiotic resistance genes, with master mix included.
- Feb 2026
Product launchReadIntroducing the Veterinary qPCR Panel Line
Five multiplex qPCR panels for research on canine and feline enteric and respiratory pathogens and dermatophytes, each paired with a matched master mix.
- Jan 2026
Company newsReadMade in the USA
How Bandit Biosystems designs, manufactures and supports its qPCR panels, reagents and NGS kits in the United States.
- Dec 2025
Company newsReadBandit Biosystems Begins Operations
Bandit Biosystems begins operations to continue the development, manufacture and support of multiplex qPCR panels, master mixes and RhinoSeq™ NGS library prep.
Archive
SeqOnce Biosciences press releases and posts
These items were originally published by SeqOnce Biosciences, Inc., a separate company. They are kept for historical and technical reference, have not been updated, and speak only as of their original dates. They are not statements by Bandit Biosystems, Inc.
15 archived items, including 10 press releases
- Jul 2025
Press releaseReadSeqOnce Biosciences – Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel
CARLSBAD, Calif., July 1, 2025 /PRNewswire/ – SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has…
- Jan 2023
Press releaseReadSeqOnce BioSciences Completes Relocation to Carlsbad, CA
New Research Facility to Advance Genomics SeqOnce Biosciences, Inc., a genomics company creating new tools to detect and analyze human disease, is thrilled to announce it has officially completed their move into a new…
- Feb 2022
Press releaseReadSeqOnce Biosciences Launches AzureSeq Direct Saliva for Detection of SARS-CoV-2
New assay for symptomatic and asymptomatic individuals detects SARS-CoV-2 in saliva without extraction February 3, 2022 SeqOnce Biosciences announces the launch of a new kit and controls for screening symptomatic and…
- Mar 2021
Press releaseReadSeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern
New assay detects Brazilian and South African SARS-CoV-2 variant faster than sequencing, screens more samples Pasadena, CA., Mar 8, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq…
- Jan 2021
Press releaseReadSeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant
Assay quickly identifies mutation found in U.K. SARS-CoV-2 N501Y Pasadena, CA., Jan 27, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of…
- Jul 2020
Press releaseReadSeqOnce Biosciences Launches AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR Kit
Pasadena, CA., July 14, 2020 – SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of novel coronavirus, SARS-CoV-2. This kit allows for fast…
- Oct 2019
Poster or technical noteReadRhinoSeq ASHG Poster 2019 – A 12 Minute, Single Tube, Nanogram Input Library Prep for Multiple NGS Applications
Next Generation Sequencing (NGS) library construction is a workflow bottleneck. The processes of library construction for DNA and RNA sequencing are complex, error prone, costly, and in general are me consuming . Current…
- May 2019
Poster or technical noteReadUnderstanding NGS Library Complexity: Sources of Sequencing Errors & Limits of Detection
Next-generation sequencing is, by definition, “massively parallel.” While the first 454/Curagen GS20 systems yielded a million reads per run, the latest sequencing platforms from Illumina, (NovaSeq 6000 running their…
- Apr 2019
BlogReadIntroducing the SeqOnce and Done Blog and the Team Behind the Technology
SeqOnce is a company founded upon the idea that steps involved in Next Generation Sequencing (NGS) need to be both streamlined and simplified. Having developed and launched the first product, RhinoSeq, NGS library…
- Mar 2019
Poster or technical noteReadRhinoSeq ABRF Poster 2019 – A 12-Min, Single Tube, Nanogram Input, Library Prep
Current next Generation Sequencing (NGS) library construction is a bottleneck in the sequencing workflow. The processes of library construction for DNA and RNA sequencing are complex, error prone, costly, and time…
- Mar 2019
Press releaseReadSeqOnce Biosciences Launches RhinoSeq Rapid DNA Library Preparation Kit
Pasadena, March 21, 2019 — SeqOnce Biosciences Inc. launches its new RhinoSeq ™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit chemistry that make…
- Feb 2019
Press releaseReadNext Generation Sequencing Sample Solutions, Simplified
Murrieta Genomics and SeqOnce Biosciences Team to Simplify and Commercialize Next Generation Sequencing Sample Preparation MURRIETA CA, February 20th, 2019 – Murrieta Genomics , the genomic sequencing business incubator…
- Sep 2018
Press releaseReadJoe Dunham Wins Biocom Life Science Catalyst Award
This article was originally posted on BusinessWire on September 13, 2018. Biocom, the association representing the California life science industry, today announced the winners of its third annual Life Science Catalyst…
- May 2018
Press releaseReadSeqOnce Biosciences Secures Series Seed Financing
This article was originally posted on PRWeb on May 10, 2018. Investor names have been removed. SeqOnce Biosciences, Inc. announced today it has completed a Sign in for pricing million series seed capital funding round. The funds will be…
- May 2018
News coverageReadStartup SeqOnce Raises Sign in for pricingM in Seed Funding
This article was originally posted on GenomeWeb on May 8, 2018. Investor names have been removed. NEW YORK (GenomeWeb) – SeqOnce Biosciences announced on Monday that it has closed a Sign in for pricing million seed financing round.…
In the media
Coverage and wire copies of SeqOnce Biosciences announcements on third-party sites. These links open external pages that Bandit Biosystems does not control.
- Jan 2023
BioSpaceOpen - Feb 2021
Medical Laboratory ObserverOpen - Feb 2021
Drug Discovery NewsOpen - Oct 2020
Omixon (in German)Open - Jul 2020
Bio-IT WorldOpen - Mar 2019
PRWebOpen - Mar 2019
GenomeWebOpen - Feb 2019
PRWebOpen
For current products, specifications and availability, see our product pages. For Research Use Only. Not for use in diagnostic procedures.